Literature DB >> 10605730

Pleckstrin homology domains and phospholipid-induced cytoskeletal reorganization.

A D Ma1, C S Abrams.   

Abstract

At the moment of hemostasis, the platelet must be able to reorganize its cytoskeleton through a complexly orchestrated signaling cascade that is regulated, in part, by polyphosphoinositides. In the past 6 years, evidence has accumulated that PH domains bind these polyphosphoinositides and play a role in cytoskeletal changes. Work to date implies that the amino-terminal PH domain of pleckstrin induces a shift of F-actin towards the cell cortex and participates in the production of lamellipodia. The effect of pleckstrin on actin is, in turn, regulated by the phosphorylation of pleckstrin by PKC. Evidence also suggests that PH domains of Dbl family exchange factors play a role in the PI3K-stimulated activation of Rac. It is likely that the PH domains of pleckstrin, as well as the PH domains of the Dbl family of exchange factors, are only a few examples of PH domains that are able to influence the organization of the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10605730

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

Review 1.  The actin cytoskeleton in store-mediated calcium entry.

Authors:  J A Rosado; S O Sage
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

2.  Diagnostic importance of platelet parameters in patients with acute coronary syndrome admitted to a tertiary care hospital in southwest region, Saudi Arabia.

Authors:  Abdullah S Assiri; Abdul-Moneim Jamil; Ahmed A Mahfouz; Zizi S Mahmoud; Mohamed Ghallab
Journal:  J Saudi Heart Assoc       Date:  2011-10-20

3.  Critical role for Kalirin in nerve growth factor signaling through TrkA.

Authors:  Kausik Chakrabarti; Rong Lin; Noraisha I Schiller; Yanping Wang; David Koubi; Ying-Xin Fan; Brian B Rudkin; Gibbes R Johnson; Martin R Schiller
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  The relative role of PLCbeta and PI3Kgamma in platelet activation.

Authors:  Lurong Lian; Yanfeng Wang; Julia Draznin; Don Eslin; Joel S Bennett; Mortimer Poncz; Dianqing Wu; Charles S Abrams
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

5.  Platelet volume indices correlate to severity of heart failure and have prognostic value for both cardiac and thrombotic events in patients with congenital heart disease.

Authors:  Masaki Sato; Seiji Asagai; Gen Harada; Eriko Shimada; Kei Inai
Journal:  Heart Vessels       Date:  2022-06-27       Impact factor: 1.814

6.  The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation.

Authors:  Janet Farhang-Fallah; Varinder K Randhawa; Anjaruwee Nimnual; Amira Klip; Dafna Bar-Sagi; Maria Rozakis-Adcock
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion.

Authors:  Kathleen M Woods Ignatoski; Navdeep K Grewal; Sonja Markwart; Donna L Livant; Stephen P Ethier
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

8.  Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion.

Authors:  Kris A DeMali; Christy A Barlow; Keith Burridge
Journal:  J Cell Biol       Date:  2002-12-09       Impact factor: 10.539

9.  PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages.

Authors:  H Uchida; A Kondo; Y Yoshimura; Y Mazaki; H Sabe
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

10.  Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.

Authors:  Cheng-Ping Hu; Yu Du; Yong Zhu; Chao Shi; Zheng Qin; Ying-Xin Zhao
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.